13 C magnetic resonance spectroscopy (MRS) in combination with infusion of 13 C-labeled substrates has led to unique insights into human brain metabolism and neurotransmitter cycling. However, the low sensitivity of direct 13 C MRS and high radiofrequency power requirements has limited 13 C MRS studies to predominantly data acquisition in large volumes of the occipital cortex. The purpose of this study is to develop an MRS technique for localized detection of 
INTRODUCTION
Detection of 13 C-labeling in brain metabolites using 13 C magnetic resonance spectroscopy (MRS) during administration of a 13 C-labeled substrate (e.g., [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] C]-glucose) is a powerful, noninvasive method for quantifying rates of metabolism and glutamate/glutamine (Glu/Gln) neurotransmitter cycling in the brain (1, 2) . In vivo 13 C MRS methods can be classified as either direct or indirect detection techniques. Indirect MRS techniques ( C coupling to detect protons bound to 13 C atoms, and are inherently more sensitive than direct 13 C MRS because of the larger gyromagnetic ratio of 1 H compared with 13 C. Indirect, proton-observed carbon-edited (POCE) MRS sequences have mostly been used for in vivo animal brain studies, and at relatively high magnetic field strengths (7 T and higher) (3) (4) (5) . At high field strengths, POCE benefits from good spectral resolution, and therefore the peaks of Glu and Gln are minimally overlapping. Restrictions on the radiofrequency (RF) power are less stringent in animal studies compared with MRS applications in human brain. Broadband 13 C-decoupling can therefore be applied to further simplify spectral appearance and to improve sensitivity (6) . For human applications, the amount of RF power that can be used is limited by the specific absorption rates (SARs) outlined by the Food and Drug Administration to prevent tissue heating. Furthermore, at lower magnetic fields mostly available for human studies ( < 7 T), the partial overlap of Glu and Gln in the proton spectrum compromises accurate quantification.
There are few reports of 1 H-[
13 C] MRS applications in human brain, mostly limited to acquisitions in the occipital lobe (7) (8) (9) , with some application in other brain regions emphasized on the detection of labeling in Glu (10, 11) . Due to concerns about RF heating and difficulties in obtaining adequate B 0 homogeneity, applications of 13 C MRS in the frontal lobe of human brain have relied on direct 13 C MRS and 13 C-labeling strategies that enrich the carboxylic carbons (12) (13) (14) (15) . The carboxylic carbons can be detected without localization schemes, as peaks of natural abundance lipids do not overlap with the Glu and Gln peaks. Furthermore, decoupling the long-range 1 H- 13 C couplings of the carboxylic carbons can be achieved with low RF power (14) . This robust, direct 13 C MRS technique can also be applied at 7 T with (16) or without low power decoupling (12) .
However, an MRS method that provides well-defined spatial localization of the 13 C-signal of both Glu and Gln, and can be used in the human frontal lobe, is currently lacking.
We describe a fully localized 1 H-[ 13 C] MRS technique that is selective proton-observed and carbon-edited (sel-POCE) for detection of 13 C-bound protons of aliphatic carbons while keeping SAR low by omitting 13 C-decoupling, which can be applied in the frontal lobe of human brain at 4 T. To allow quantification of the partially overlapping satellite peaks of Glu and Gln generated by 1 H- 13 C coupling, selective editing is implemented. We describe the MRS pulse sequence, and provide RF power requirements and SAR characteristics. The method's functionality is illustrated in metabolite phantoms, and human in vivo data are shown, acquired from a 45-mL voxel located in the frontal lobe during infusion of [1- 13 C]-glucose.
METHODS

General
Three healthy subjects were studied (age: 19-39 years, 2 male, 1 female). All procedures described were approved by the Yale University institutional review board. Subjects fasted overnight and presented around 7:00 a.m. at the Magnetic Resonance Research Center. Two intravenous lines were placed for infusion of [1-13 C]-glucose and blood sampling, respectively. The MRS experiments were carried out on a 4T whole-body magnet interfaced to a Bruker Avance III HD spectrometer, running on Paravision 6 (Bruker Instruments, Billerica, Massachusetts, USA). At approximately 8:00 a.m. the subjects were positioned supine on the scanner bed, and the RF coil was placed over the forehead. The RF coil setup consisted of two circular surface coils positioned 11.5 mm apart in parallel planes: an outer 13 C transmit-only coil (diameter ¼ 135 mm) and an inner 1 H transmit/receive coil (diameter ¼ 95 mm).
Magnetic Resonance Spectroscopy Acquisition
Gradient-echo MR images were acquired to confirm accurate positioning of the subject and voxel placement. Shimming of the voxel was performed using methods implemented by the manufacturer. First-and secondorder shims settings were calculated automatically following the acquisition of a B 0 map, and first-order shims were fine-tuned with an iterative shimming routine using the selPOCE method without any 13 C RF pulses (transforming it into a traditional stimulated echo acquisition mode (STEAM) sequence) for localized detection of the water signal. The RF power calibration was based on the reference power determined for a 90 flip angle acquired in a slice parallel to the 1 H surface coil and positioned to overlap with the voxel position. The sel-POCE MRS method is a combination of POCE based on stimulated echoes (17) and 2-dimensional heteronuclear single-quantum coherence MRS (18) . Figure 1 schematically illustrates the selPOCE sequence. The basic STEAM localization method (Fig. 1a) is based on 1.0-ms asymmetric Shinnar-Le Roux excitation pulses (6.1 kHz bandwidth) (19) , allowing an echo time of 7.8 ms. The mixing time period is modified to allow for a conventional POCE experiment (Figs. 1b and 1c) or a selective POCE experiment (Figs. 1d and 1e ). In the conventional POCE experiment, inversion of the 13 C spins is achieved with a 5.0-ms adiabatic full passage pulse (HS4 modulation (20) heteronuclear single-quantum coherence sequence, in which the spins evolve on the carbon-13 axis following excitation by a 0.25-ms square pulse. In our application, the 13 C transmitter frequency is on-resonance for the Glu-C4 position at 34.2 ppm. Proton-carbon scalar coupling is refocused by a 2.0-ms adiabatic full passage pulse (HS4 modulation (20) , 10 kHz bandwidth). With the Glu-C4 on-resonance, the 90(þx) -delay -90(þx) combination (Fig. 1d) leads to an inversion of the [4- 13 C]-Glu-H4 signal, whereas the 90(þx) -delay -90(-x) combination leads to an identity rotation (Fig. 1e) . The Gln-C4 resonance at 31.7 ppm is 2.5 ppm or Dn ¼ 107 Hz off-resonance compared with the Glu-C4 resonance. During mixing time the [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] C]-Gln-H4 resonance acquires a phase of 2pDnt, which can be made equal to 180 by setting t ¼ 1/2Dn. The pulse/delay combination shown in Figure 1d leads to an identity rotation for [4- 13 C]-Gln-H4, whereas the combination in 
Safety Simulations
The RF power output was measured continuously at the amplifier and corrected for the hardware losses up to the RF coil connection. Finite difference time domain simulations were carried out in Sim4Life (Z€ urich MedTech, Zurich, Switzerland) to simulate SAR 10-g distributions for the 4T 13 C and 1 H-tuned single-turn surface coils on the human model "Duke" (21) . The 1 H and 13 C surface coil models are positioned 1 and 2 cm away from the head, respectively. Both coil models are placed at an angle of 30 with respect to the coronal plane. Separate broadband simulations were carried out for each coil model. In both simulations, the unused coil was not included in the voxelated model. An isotropic voxel size of 1 mm was used to model the coil elements, resulting in a grid size of 41.10*10 6 cells for the 1 H-coil model and 40.98*10 6 cells for the 13 C-coil model. Two capacitors for tuning were included in the coil model: 2 3 37.6 pF for the 13 C coil and 2 3 3.44 pF for the 1 H coil.
Phantoms
Two different 50-mL solutions were used in phantoms to illustrate the selPOCE MRS method. One solution consisted of deionized water and approximately 60 mM of acetate (Ace): 15 mM [2-
13
C]-Ace, 40 mM lactate (Lac), and 8 mM [3- 13 C]-Lac. A second 50-mL solution consisted of deionized water and 100 mM of Glu and 80 mM of Gln. The solutions are put in a 50-mL container that was integrated into an approximate 4-L container that itself was filled with 50 mM of potassium chloride in deionized water. This setup allows for exchanging the 50-mL phantom solutions, while mimicking the electrical load on the RF coil of a human head with the 4-L potassium chloride solution. The phantom studies used the same RF coil as used in the in vivo studies, with the 50-mL phantom placed directly under and perpendicular to the coil.
Magnetic Resonance Spectroscopy Processing
Processing of MR spectra was performed with in-housebuilt software written in MATLAB (MathWorks, Natick, Massachusetts, USA) using routines similar to those previously described (22) . Briefly, the spectral fitting is based on the principle of the linear combination of model spectra (23) , in which the spectrum is approximated as a linear sum of the individual components. The basis set was simulated in MATLAB using the density matrix formalism, taking RF pulses and gradients of the pulse sequence into account. The basis set for the spectral region [0.5 . . .
and [2-
13 C]-NAA-H2 (N-acetyl aspartate) on top of a second-order, polynomial baseline. The concentration of 13 C-labeled Glu and Gln was calculated using the natural abundance signal of NAA before administration of [1- 13 C]-glucose as a 10-mM internal concentration reference. To demonstrate the value of the selPOCE scans (Figs. 1d and 1e) in addition to the standard POCE scans (Figs. 1b and 1c) , the acquired data were processed in two different ways to obtain estimates for 13 C-labeled Glu-H4 and Gln-H4. The processing options consisted of processing the conventional POCE difference data, and processing the separated [4- 13 C]-Gln-H4 concentrations under these two processing options was evaluated using the Cramer-Rao lower bounds (24) .
A primed, variable rate infusion of [1-13 C]-glucose (1.1M, 99% enriched, Cambridge Isotopes, Cambridge, Massachusetts, USA) was performed to rapidly reach plasma glucose concentrations of approximately 10 mM. Toward the end of the infusion (90-120 min), the plasma glucose level was allowed to naturally drop to approximately 7 mM. Venous blood was sampled every 5 min, spun down, and plasma glucose concentration was measured using a YSI 2700 STAT Analyzer (Yellow Springs Instruments, Yellow Springs, Ohio, USA). Remaining plasma was stored at 280 C until used for measurement of glucose 13 C fractional enrichment.
Plasma Glucose 13 C Fractional Enrichment
Plasma (100 mL) was diluted with 500-mL phosphate buffer (100 mM) containing 10% D 2 O and 2 mM formic acid as chemical shift reference. Pulse-acquired 1 H MR spectra were collected on a 500-MHz MR spectrometer (Bruker Avance). The fractional enrichment of [1- 13 C]-glucose was derived from the integrals of the downfield satellite (5.39 ppm) and the central peak (5.22 ppm), quantified using in-house-built software written in MATLAB. 
RESULTS
Safety Simulations
Phantom Studies
The underlying principles of the selPOCE are experimentally demonstrated on the phantom solutions containing unlabeled and 13 C-labeled acetate and lactate. In the conventional STEAM spectrum (Fig. 3a) , all signals appear positive, whereas the application of a broadband carbon-13 inversion pulses leads to a phase inversion of all resonances with a one-bond 1 H-13 C scalar coupling (Fig. 3b) . The difference between Figures 3a and 3b provides the conventional POCE spectrum (Fig. 3e) , in which all signals without a one-bond 1 H-13 C scalar coupling have been eliminated. Besides the 1 H chemical shift difference between [2- 13 C]-Ace-H2 and [3-13 C]-Lac-H3, the POCE difference spectrum does not provide any intrinsic discrimination between the two compounds. This poses a problem when the 1 H chemical shift difference is very small, leading to spectral overlap. Such is the case for Gln and Glu, which will be discussed in Figures 4 to 7 . Figures 3c and 3d show that the phase of [2- 13 C]-ace-H2 and [3-
13 C]-Lac-H3 can be selectively manipulated with the heteronuclear single-quantum coherence pulse sequence elements shown in Figures 1d and 1e . With the 13 C resonance of [3- 13 C]-Lac-H3 being on-resonance and the mixing time set to 3.8 ms, the 1 H resonances of [3- 13 C]-Lac-H3 (Fig. 3c) and [2-13 C]-Ace-H2 (Fig. 3d ) are selectively phase-inverted based on the 3.0-ppm 13 C chemical shift difference. The difference between Figures 3c and 3d also provides a POCE spectrum (Fig. 3f) of signals with one-bond 1 H-13 C coupling, in which the two compounds are phase-inverted relative to each other. Combining the two POCE difference spectra (Figs. 3e and 3f) by addition and subtraction provides pure [2- 13 C]-Ace-H2 and [3-13 C]-Lac-H3 spectra, respectively. Figure 4 shows data from the phantom containing 100-mM Glu and 80-mM Gln, and illustrates how selPOCE can be applied for the selective detection of [4- 13 C]-Glu-H4 and [4- 13 C]-Gln-H4. The POCE (Fig. 4b ) difference spectrum shows the 1.1% natural abundance signals of [4- 13 C]-Glu-H4 and [4- 
In Vivo MRS
Compared with the phantom data of Glu and Gln (Fig.  4) , the faster in vivo T Ã 2 relaxation make the Glu and Gln overlap even more problematic, as shown in the 1 H MR spectrum acquired in the frontal lobe of a healthy volunteer (Fig. 5) . Despite the high magnetic field homogeneity (typical full-width half-maximum linewidth values for water: 9.5 6 1.2 Hz), Glu and Gln peaks in the 1 H MR spectrum acquired in a 45-mL (5 3 3 3 3 cm 3 ) voxel positioned in the frontal lobe (Fig. 5a ) are overlapping significantly (Fig. 5b) . The SelPOCE spectra collected in 12 min from the frontal lobe voxel during infusion of [1- 13 C]-glucose are shown in Figures 5c to 5f. Similar to the results obtained in the Glu-Gln phantom, subtraction of selPOCE subspectra generates difference spectra of all 13 C-bound protons (Fig. 5c) , as well as individual MR spectra of [4- 13 C]-Glu-H4 (Fig. 5e ) and [4-13 C]-Gln-H4 (Fig. 5f) C]-Gln-H3, combined as unresolved [3- 13 C]-Glx-H3, can be observed. If labeling occurs in [3- 13 C]-Asp-H3 and [3-13 C]-Lac-H3, these peaks can be unambiguously quantified from the conventional POCE difference spectrum because of minimal overlap with other resonances. Figure 6 shows the quantification of POCE spectra using various combinations of data inclusion. Analysis of the conventional POCE spectrum alone (Fig. 6a) provides an adequate mathematical fit of [4- 13 C]-Glu-H4, [4-
13
C]-Gln-H4, [3- 13 C]-Glx-H3 and [3-13 C]-Lac-H3, and resulted in reasonable estimates of [4- 13 C]-Glu-H4 and [4-13 C]-Gln-H4 concentrations (Fig. 7a ). However, the high level of spectral overlap leads to high Cramer-Rao lower bounds (Fig.  7b) for Glu (5.8%) and especially Gln (28.4%). Processing of the separated [4- 13 C]-Glu-H4 (Fig. 6b) and [4-13 C]-Gln-H4 (Fig. 6c ) subspectra simultaneously leads to improved Cramer-Rao lower bounds (2.3% for Glu and 7.0% for Gln) compared with the fitting of the conventional POCE spectrum (Fig. 7b) . Note that the [3-
13 C]-Glx-H3 and [3- 13 C]-glucose can be seen in the serially acquired selPOCE difference spectra, depicted in Figure  8 . The different combinations of selPOCE spectra reveal the 13 C-labeling of Glu-H4 and Gln-H4 in separate, yet simultaneous time courses. The appearance of 13 C-labeling shows the predictable labeling pattern of [1- 13 C]- C concentration and Cramer-Rao lower bounds. a: Concentration of 13 C-labeled Glu-H4 (black) and Gln-H4 (gray) calculated based on the fitted spectra of the conventional POCE acquisition, and simultaneous fitting of the Glu and Gln subspectra calculated from selPOCE spectra, with accompanying CramerRao lower bounds (b) for each fitting approach. Note the improved Cramer-Rao lower bounds achieved when fitting the sel-POCE spectra compared with conventional POCE.
glucose infusions, with Glu labeling preceding the labeling of the (smaller) Gln pool.
DISCUSSION
Two major limitations in the application of 1 H-[ 13 C] MRS to human brain are the poor ability to separate Glu and Gln and the requirement for decoupling to simplify the 1 H-[ 13 C] edited spectra. We described an MRS method implemented at 4 T that uses indirect detection of 13 C via 1 H, and enables measuring the rate and degree of Glu and Gln 13 C-labeling in a well-defined volume in the frontal lobe of human brain. To operate within the Food and Drug Administration guidelines for RF power deposition, 13 The MRS method was demonstrated by acquiring 13 Clabeling data from a 45-mL voxel in the frontal lobe of healthy volunteers during infusion of [1- 13 C]-glucose. An important characteristic of the selPOCE method is the lack of 13 C-decoupling. This significantly reduces the required RF power and allows staying comfortably within the SAR limits defined by the Food and Drug Administration (3 W/kg). The lack of decoupling complicates the spectral appearance, because the multiplet peaks from 13 C-bound protons of Glu and Gln are split into two. However, the predictable appearance of the MR signals can be accurately simulated using the density matrix formalism and used for spectral fitting of the sel-POCE MR spectra, by means of the widespread method of linear combination of model spectra (23) . The linear combination of model spectra data illustrate high-quality spectral fitting of the multiplet peaks in the selPOCE difference spectra, resulting in Cramer-Rao lower bounds of 5 to 10%. The anticipated loss in sensitivity as a result of the lack of 13 C-1 H decoupling is thus adequately compensated by the selective detection of Glu and Gln in the separate scans. Another aspect of the sequence that contributes to its overall low RF power requirement is the use of stimulated echoes generated with 90 pulses instead of relying on spin echoes produced with 180 pulses. The STEAM-based MRS sequence provided highquality localization, as no lipid signal from the scalp was observed, all at a fraction of the Food and Drug Administration SAR limits.
For 13 C MRS studies with infusion of 13 C-labeled substrates of brain metabolism and neurotransmitter cycling, it is crucial to quantify both Glu and Gln labeling. Glu and Gln are partially overlapping in the 1 H MR spectrum at 4 T and even more at 3 T. The presented selPOCE method achieves individual detection of Glu and Gln by using frequency-selective pulses in the 13 C domain and timing the sequence to allow the coherence to evolve to result in an opposite phase in the 1 H domain. As demonstrated in the Lac/Ace phantom, the technique can be applied to separate other metabolites than Glu and Gln in the 1 H domain as well, as long as their respective 
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De Feyter et al. resonances in the 13 C domain are not overlapping, such as GABA and Glu. A pulse sequence variant based on heteronuclear multiple-quantum coherence (HMQC) was previously described on rat brain to separate [3- 13 C]-Glu-H3 and [4- 13 C]-Glu-H4 (25) . The data presented were acquired on a 4T clinical research scanner. At the common field strength of 3 T, the overlap of Glu and Gln in the 1 H MR spectrum is even larger than at 4 T. However, the Glu and Gln peaks at 3 T are still well-separated on the 13 C frequency domain, and therefore the selPOCE method could easily be used at 3 T as well. For applications at 7 T, the benefit of selecting Glu and Gln is less of an issue because of the improved spectral resolution. However, the low RF power requirements of the selPOCE method would be the key aspect that allows for this technique to be implemented at 7 T, where SAR limits are significantly more difficult to adhere to. Echo time optimization and variation in a point-resolved spectroscopy sequence has been used as a strategy to separate the partially overlapping resonances of Glu and Gln (11) . The point-resolved spectroscopy method will not have the 50% signal-to-noise ratio penalty inherent to the STEAM sequence. However, some signal loss will be induced as a result of the typically longer echo time in a point-resolved spectroscopy sequence optimized for Glu and Gln separation. In addition, the refocusing pulses of the point-resolved spectroscopy sequence will significantly increase the RF power requirements, which will simultaneously provide a smaller bandwidth and hence a larger chemical shift displacement error.
Using a simple setup of two coplanar surface coils for RF transmission ( 1 H and 13 C) and reception ( 1 H) provided high-quality selPOCE data from a volume of 45 mL. The RF coil setup did not include extensive measures to decouple the 1 H and 13 C coils, as no 1 H- 13 C decoupling is applied during acquisition. Various strategies could be implemented to improve the design of the RF setup. A volume resonator could be used for transmission ( 1 H and 13 C), providing homogenous flip angles of the RF pulses. This could be combined with an array of 1 H surface coils for reception, which would increase the signal-to-noise ratio and the area covered by the receive coils. These improvements would allow for sel-POCE spectra acquisition from a smaller volume than used in the present study, and provide more freedom for voxel positioning. In addition, a multivoxel approach could be implemented, ideally combined with dynamic shim updating to acquire selPOCE spectra from different brain regions simultaneously (26) . In addition, a close to doubling of the signal-to-noise ratio of [4- 13 C]-Glu-H4 and [4-13 C]-Gln-H4 could be achieved by using [1, [6] [7] [8] [9] [10] [11] [12] [13] C 2 ]-glucose. Metabolism of [1, [6] [7] [8] [9] [10] [11] [12] [13] C 2 ]-glucose results in both glucose-derived triose molecules being 13 C-labeled instead of only one triose being labeled during metabolism of [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] C]-glucose. However, at this time, the cost of [1, [6] [7] [8] [9] [10] [11] [12] [13] C 2 ]-glucose does present a hurdle for its application in human studies, as an average dose of glucose of 50 g is used.
CONCLUSIONS
We have illustrated the functionality of the selPOCE MRS technique in the frontal lobe of human brain during [4- 13 C]-Glu-H4 and [4-13 C]-Gln-H4. The SelPOCE method retains much of the enhanced sensitivity of conventional POCE-type sequences, potentially allowing significant improvements in the spatial resolution for measuring neuroenergetics and neurotransmitter cycling over the presently used direct-detection 13 C MRS methods.
